scholarly journals Can surgical adhesives may cause false positivity in follow-up positron emission tomography after lung cancer resection?

2021 ◽  
Vol 69 (1) ◽  
pp. 59-64
Author(s):  
Rıza Doğan ◽  
Serkan Uysal ◽  
Ulaş Kumbasar ◽  
Deniz Köksal ◽  
Burcu Ancın ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Positron Emission Tomography ◽  
Emission Tomography ◽  
Cancer Resection ◽  
False Positivity ◽  
Positron Emission

Traditional Versus Up-Front [18F] Fluorodeoxyglucose–Positron Emission Tomography Staging of Non–Small-Cell Lung Cancer: A Dutch Cooperative Randomized Study

2006 ◽  
Vol 24 (12) ◽  
pp. 1800-1806 ◽  
Author(s):  
Gerarda J.M. Herder ◽  
Henk Kramer ◽  
Otto S. Hoekstra ◽  
Egbert F. Smit ◽  
Jan Pruim ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Positron Emission Tomography ◽  
Final Stage ◽  
Clinical Stage ◽  
Randomized Study ◽  
Tnm Staging ◽  
Emission Tomography ◽  
Positron Emission

Purpose We investigated whether application of positron emission tomography (PET) immediately after first presentation might simplify staging while maintaining accuracy, as compared with traditional strategy in routine clinical setting. Methods At first presentation, patients with a provisional diagnosis of lung cancer without overt dissemination were randomly assigned to traditional work-up (TWU) according to international guidelines or early PET followed by histologic/cytologic verification of lesions, or imaging and follow-up. Patients with [18F] fluorodeoxyglucose (18FDG) –avid, noncentral tumors without suspicion of mediastinal or distant metastases on PET proceeded directly to thoracotomy. Follow-up in presumed benign lesions was at least 12 months. In patients treated with surgery or neoadjuvant therapy, the quality of staging was measured by comparing the clinical stage to the final stage (combination of peroperative staging and 6 months of follow-up). To investigate test substitution, we analyzed the number of (non)invasive tests to achieve clinical TNM staging, and its associated costs. Results Between 1999 and 2001, 465 patients (233 TWU, 232 PET) were enrolled at 22 hospitals. The mean (standard deviation) number of procedures to finalize staging was equal in the TWU arm and the PET arm: 7.9 (2.0) v 7.9 (1.9), P = .90, respectively. Mediastinoscopies occurred significantly less often in the PET arm. Agreement between clinical and final stage was good in both arms (κ = .85 v .78; P = .07). Costs did not differ significantly. Conclusion Up-front 18FDG-PET in patients with (suspected) lung cancer does not reduce the overall number of diagnostic test, but it maintains quality of TNM staging with the use of less invasive surgery.

False Positivity and False Negativity on Positron Emission Tomography in a Patient with Lung Cancer

2013 ◽  
Vol 13 (4) ◽  
pp. 174-177
Author(s):  
Evrim Eylem Akpinar ◽  
Ahmet Hakan Haliloglu ◽  
Emel Ozturk ◽  
Meral Gulhan
Keyword(s):  
Lung Cancer ◽  
Positron Emission Tomography ◽  
Emission Tomography ◽  
False Positivity ◽  
Positron Emission
Sign in / Sign up

Export Citation Format

Share Document